About Apotex Pharmachem India Private Limited
Data last updated:
Apotex Pharmachem India Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Apotex Pharmaceuticals Holdings Inc.. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 16 June 2003 and has been in existence for over 23 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24231KA2003PTC032104. Its GSTIN is 29AACCB1658E1ZT (Karnataka).
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹76.31 Cr. It was formerly known as Brantford Chemicals Private Limited. It is led by directors including Brian George Mcclelland and Yoganjaneya Reddy Panem.
Its last annual general meeting (AGM) was held on 24 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Site No. 1 A Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Bangalore, Karnataka, India – 562158.
As per the financials filed for FY 2024, the company reported a revenue of ₹142.14 Cr, a decline of 19% compared to the previous year. For the same year it recorded a net profit of ₹14.45 Cr (net margin 10.2%) and EBITDA of ₹30.22 Cr (EBITDA margin 21.3%). Revenue has declined at a compounded annual rate (CAGR) of 6% over three years and 10% over five years.
The company has about 209 employees on its provident fund (EPFO) records.
The company is associated with 2 brands: Apotex Pharmachem India and Apotex Pharmachem. As per MCA filings, the company has satisfied charges of ₹137.2 Cr on record. Court records list 8 cases involving the company, including 7 filed by the company and 1 filed against it. The company has 2 deals on record (2 funding rounds), with disclosed funding of ₹67.15 Cr; the latest was in March 2010. Its 7 peer companies in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 4 smaller; the largest is Goodway Chemicals Private Limited with revenue of ₹144.1 Cr. The company has 12 MSME Form 1 returns on record between 2015 and 2024, listing 106 overdue payments to 32 micro and small suppliers.
The current compliance status is marked as active non-compliant by the Registrar of Companies. For more details, the company can be reached via its website apotexpharmachem.com.
Company details
Contact details
Apotex Pharmachem India Private Limited's registered office is in Bangalore, Karnataka. Its website is apotexpharmachem.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSite No. 1 A Bommasandra Industrial Area 1V Th Phase Jigani Link Road, Bangalore, Karnataka, India – 562158
- IndustryPharma, API Manufacturers
To see the full contact details of Apotex Pharmachem India Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Brands
Apotex Pharmachem India operates two associated brands: Apotex Pharmachem India and Apotex Pharmachem. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Develops, manufactures, and commercializes generic, biosimilar, and innovative branded medicines for patient care. | apotex.co.in | |
| Manufactures active pharmaceutical ingredients as a traditional pharma company. | apotexpharmachem.com |
Business activity
The main business activities of Apotex Pharmachem India are manufacturing and professional, scientific and technical. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and scientific research and development. 2 activity segments are registered with the MCA.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | |
| M | Professional, Scientific and Technical | M5 | Scientific research and development |
To see the full business activity and turnover split of Apotex Pharmachem India Private Limited, buy the company report.
Financials of Apotex Pharmachem India Private Limited
FY 2024 filings availableApotex Pharmachem India Private Limited reported revenue of ₹142.14 Cr (down 19% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 10% over five years, including a 19% fall in the latest year. EBITDA fell 26% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹30.22 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹14.45 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.3% | ||||
| Net Profit Margin | 10.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Apotex Pharmachem India Private Limited, buy the company report.
Board of directors of Apotex Pharmachem India Private Limited
Apotex Pharmachem India has 4 current directors and 11 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Brian George Mcclelland Also directs: Apotex Research Private Limited | Director | 15 Sep 2023 | 3 Years 1 Months | Current |
| Yoganjaneya Reddy Panem | Director | 09 Jun 2015 | 11 Years 4 Months | Current |
| Kajal Palan | Additional Director | 03 May 2024 | 2 Years 5 Months | Current |
| Uta Kellermann Renton Also directs: Apotex Research Private Limited | Director | 23 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Apotex Pharmachem India Private Limited is compared with the 7 companies closest to it by revenue in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Goodway Chemicals Private Limited | ₹144.1 Cr (FY 2025) | -12.0% | Mumbai, Maharashtra, India | |||
| Immacule Lifesciences Private Limited | ₹143.18 Cr (FY 2025) | 34.0% | Nalagarh, Himachal Pradesh, India | |||
| Alventa Pharma Limited | ₹142.72 Cr (FY 2025) | 82.0% | Kolkata, West Bengal, India | |||
| Apotex Pharmachem India Private Limitedthis company | ₹142.14 Cr (FY 2024) | ₹14.45 Cr | 10.2% | -19.0% | 209 | Bangalore, Karnataka, India |
| Sovereign Pharma Private Limited | ₹142.09 Cr (FY 2025) | 15.0% | Mumbai, Maharashtra, India | |||
| Svizera Labs Private Limited | ₹142.05 Cr (FY 2022) | 7.0% | Thane, Maharashtra, India | |||
| Ratnatris Pharmaceuticals Private Limited | ₹141.71 Cr (FY 2025) | 35.0% | Ahmedabad, Gujarat, India | |||
| Lyka Labs Limited | ₹140.73 Cr (FY 2025) | 25.0% | Ankleshwar, Gujarat, India |
To see the full peer comparison of Apotex Pharmachem India Private Limited, buy the company report.
Auditor
Apotex Pharmachem India Private Limited is audited by HARIBHAKTI & CO. LLP for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| HARIBHAKTI & CO. LLP | FY 2023 | 103523W / W100048 |
Shareholding
The shareholding of Apotex Pharmachem India Private Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Apotex Pharmachem India Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 21 Jul 2016 | 100044632 | The Hongkong and Shanghai Banking Corporation Limited | ₹60 Lakh | Satisfied | |
| 24 Apr 2014 | 10503185 | The Hongkong and Shanghai Banking Corporation Limited | ₹19.8 Cr | Satisfied | |
| 27 Sep 2013 | 10452552 | The Hongkong and Shanghai Banking Corporation Ltd | ₹19.8 Cr | Satisfied | |
| 12 Jan 2010 | 10205214 | State Bank of India | ₹32 Cr | Satisfied | |
| 31 Mar 2006 | 10004977 | Apotex Pharmaceutical Holdings Inc | ₹65 Cr | Satisfied |
To see the full charge records of Apotex Pharmachem India Private Limited, buy the company report.
Total charge records: 5 View all charges
Deals & funding
Apotex Pharmachem India Private Limited has 2 deals on record (2 funding rounds), with disclosed funding of ₹67.15 Cr; the latest was in March 2010.
Deals on record (2 of 2)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2010 | Funding round | ₹18.45 Cr | Investors: Apotex Pharmaceutical Holdings Inc |
| Jun 2007 | Funding round | ₹48.7 Cr | Investors: Apotex Pharmaceutical Holdings Inc |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Apotex Pharmachem India Private Limited has 8 court cases on record: 7 filed by Apotex Pharmachem India, 1 filed against it. All cases are disposed.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 8 | 1 | 0 |
Cases on record (4 of 8)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court of Karnataka | Writ petition | Filed by the company against Government of Karnataka | Disposed |
| High Court | Tax appeal | Filed against the company by The PR. Commissioner of Income Tax and 1 other | Disposed |
| High Court of Karnataka | Tax appeal | Filed by the company against The Deputy Commissioner of Income Tax | Disposed |
| High Court of Karnataka | Writ petition | Filed by the company against The State of Karnataka Reptd by Its Finance Secy | Disposed |
To see the full case history of Apotex Pharmachem India Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Apotex Pharmachem India Private Limited has 12 MSME Form 1 returns on record between 2015 and 2024, listing 106 overdue payments to 32 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 32)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Labsupplies India Private Limited | |||
| Lee Pharma Limited | |||
| CRL Interior and Fit Out Private Limited | |||
| Reliable Agencies | |||
| Aic Enterprises Private Limited |
To see the full MSME payment records of Apotex Pharmachem India Private Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Apotex Pharmachem India Private Limited has a workforce of 209 employees on its EPFO records as of Apr 04, 2024, across 1 active EPFO establishment.
GST
Apotex Pharmachem India has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 29AACCB1658E1ZT | Karnataka | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Apotex Pharmachem India Private Limited, buy the company report.
Recent activity
Apotex Pharmachem India Private Limited has 15 board changes on record since 2009: 4 appointments and 11 cessations. The latest: Uta Kellermann Renton ceased to be Additional Director on 25 Sep 2025.
18 earlier events are in the company report.
Frequently asked questions
Apotex Pharmachem India is an active private limited company based in Bangalore, Karnataka, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 16 June 2003 (23+ years old) and is registered under CIN U24231KA2003PTC032104.
Apotex Pharmachem India has 4 current directors:
- Brian George Mcclelland - Director
- Yoganjaneya Reddy Panem - Director
- Kajal Palan - Additional Director
- Uta Kellermann Renton - Director
The latest financial statements of Apotex Pharmachem India on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 24 September 2024. Year-wise statements from 2015 are in the company report.
The GSTIN of Apotex Pharmachem India is 29AACCB1658E1ZT, registered in Karnataka.
The CIN (Corporate Identification Number) of Apotex Pharmachem India is U24231KA2003PTC032104. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Apotex Pharmachem India has 8 court cases on record: 7 filed by the company and 1 filed against it.
Apotex Pharmachem India was incorporated on 16 June 2003, making it 23+ years old. It is registered with the Registrar of Companies, Bangalore.
Apotex Pharmachem India has 2 deals on record (2 funding rounds), with disclosed funding of ₹67.15 Cr; the latest was in March 2010.
The peers of Apotex Pharmachem India by revenue are Goodway Chemicals Private Limited, Immacule Lifesciences Private Limited, Alventa Pharma Limited, Sovereign Pharma Private Limited, Svizera Labs Private Limited and 2 more, all in the Pharma industry (Formulations), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Uta Kellermann Renton ceased to be Additional Director on 25 Sep 2025. Uta Kellermann Renton was appointed as Director on 23 Sep 2025. Kajal Palan ceased to be Additional Director on 23 Sep 2024. Apotex Pharmachem India has 15 board changes on record in total.
Apotex Pharmachem India has 12 MSME Form 1 returns on record between 2015 and 2024, listing 106 overdue payments to 32 micro and small suppliers. The latest return was filed on 24 Apr 2024.
Apotex Pharmachem India can be reached through the website apotexpharmachem.com. Its registered office is in Bangalore, Karnataka, India.